- Home
- CLOV
as of 01-09-2026 3:45pm EST
$2.58
+$0.04
+1.38%
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $3.35 | AVG Volume (30 days): | 4.4M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.12 - $4.87 | Next Earning Date: | 02-26-2026 |
| Revenue: | $1,773,564,000 | Revenue Growth: | 32.15% |
| Revenue Growth (this year): | 41.68% | Revenue Growth (next year): | 37.69% |
AI-Powered CLOV Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 76.92%
76.92%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Jan 7, 2026
Avg Cost/Share
$2.53
Shares
2,102
Total Value
$5,318.06
Owned After
2,757,029
SEC Form 4
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Dec 18, 2025
Avg Cost/Share
$2.61
Shares
4,913
Total Value
$12,822.93
Owned After
2,757,029
SEC Form 4
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Nov 4, 2025
Avg Cost/Share
$3.58
Shares
30,385
Total Value
$108,778.30
Owned After
2,757,029
SEC Form 4
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Oct 17, 2025
Avg Cost/Share
$2.69
Shares
16,514
Total Value
$44,422.66
Owned After
2,757,029
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jan 7, 2026 | Sell | $2.53 | 2,102 | $5,318.06 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Dec 18, 2025 | Sell | $2.61 | 4,913 | $12,822.93 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Nov 4, 2025 | Sell | $3.58 | 30,385 | $108,778.30 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 17, 2025 | Sell | $2.69 | 16,514 | $44,422.66 | 2,757,029 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
Simply Wall St.
Top Insider-Owned Growth Companies To Watch In January 2026
Simply Wall St.
3 Penny Stocks With Market Caps Reaching $2B
Compare CLOV vs Leading Stocks
See how CLOV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.